Intranasal Corticosteroids for Allergic Rhinitis

Efficacy Comparison

• Intranasal corticosteroids are the most effective medication class for treating allergic rhinitis, superior to antihistamines and leukotriene receptor antagonists 1, 2
• The clinical response does not appear to vary significantly between available intranasal corticosteroids, including fluticasone propionate and mometasone furoate 1, 2
• Both medications effectively control all four major symptoms of allergic rhinitis: sneezing, itching, rhinorrhea, and nasal congestion 2
• Onset of therapeutic effect for intranasal corticosteroids occurs between 3-12 hours after administration 1, 3

Safety Profile

• Both fluticasone propionate and mometasone furoate have excellent safety profiles when used at recommended doses 1, 4
• Studies with both fluticasone propionate and mometasone furoate have shown no effect on growth at recommended doses compared to placebo 4
• Neither medication has demonstrated clinically significant effects on hypothalamic-pituitary-adrenal (HPA) axis function 1, 4
• Neither medication has demonstrated clinically significant effects on ocular pressure or cataract formation 4
• Neither medication has demonstrated clinically significant effects on bone density 4

Administration Considerations

• As-needed dosing of fluticasone propionate has been shown to be effective for seasonal allergic rhinitis, though continuous use may be more efficacious 1, 2
• A patent nasal airway is necessary for optimal delivery of either medication; a nasal decongestant may be beneficial for several days when initiating therapy 2, 3

Special Populations

• Both medications are effective for non-allergic rhinitis, especially NARES and vasomotor rhinitis 1, 2
• In children, both fluticasone propionate and mometasone furoate have demonstrated safety at recommended doses 4
• Growth suppression has only been reported with long-term use of beclomethasone dipropionate that exceeded recommended doses, not with either fluticasone or mometasone 4

Common Pitfalls and Caveats

• Local side effects such as nasal irritation and bleeding are rare with both medications but can be minimized with proper administration technique 4
• Preparations containing propylene glycol and benzalkonium chloride may cause local irritation or ciliary dysfunction 4
• For patients with inadequate response to monotherapy, adding an oral antihistamine may provide additional benefit for some symptoms, particularly pruritus 5, 3
• Approximately 50% of patients with seasonal allergic rhinitis may require both intranasal corticosteroids and oral antihistamines for adequate symptom control 5, 3

Comparative Efficacy vs Other Treatments

• Both fluticasone and mometasone are more effective than oral antihistamines for controlling nasal symptoms 5
• Intranasal corticosteroids are generally more effective than the combined use of an antihistamine and a leukotriene antagonist 1, 2
• PRN use of fluticasone propionate has been shown to be superior to PRN use of oral antihistamines for seasonal allergic rhinitis 1, 2

Role of Fluticasone Nasal Spray in Allergic Rhinitis

Efficacy and Symptom Control

• The American Academy of Allergy, Asthma, and Immunology recommends fluticasone nasal spray for effective relief of nasal congestion, with significant reductions in symptoms, including congestion upon awakening, which is a key advantage over oral antihistamines 6
• Fluticasone nasal spray provides limited benefit for associated eye symptoms, but is effective for nasal symptoms, with significant reductions maintained throughout treatment 6

Practical Administration and Adherence

• The American College of Allergy, Asthma, and Immunology suggests maintaining regular daily use of fluticasone nasal spray throughout the allergen exposure season, rather than stopping when symptoms resolve, as continuous treatment is more effective than intermittent use 6

Treatment of Allergic Rhinitis with Fluticasone and Mometasone

Age-Specific Recommendations

• For children aged 2-3 years, the American Academy of Otolaryngology-Head and Neck Surgery recommends mometasone furoate as the preferred choice, due to its FDA approval for children ≥2 years at 1 spray per nostril daily (100 mcg total) 7
• For children aged 4-11 years, either fluticasone propionate or mometasone furoate is appropriate, with dosing at 1 spray per nostril daily (50 mcg per spray for fluticasone, same dosing for mometasone) 7
• For adolescents ≥12 years and adults, both medications are dosed at 2 sprays per nostril once daily (fluticasone 200 mcg total; mometasone 200 mcg total) 7

Common Side Effects

• The American Academy of Otolaryngology-Head and Neck Surgery reports that fluticasone propionate and mometasone furoate have nearly identical adverse event profiles, including headache, pharyngitis, epistaxis, nasal burning/irritation, nausea, vomiting, asthma symptoms, and cough 7

Contraindications and Monitoring

• Both medications are contraindicated in patients with hypersensitivity to the medication or its components, according to the American Academy of Otolaryngology-Head and Neck Surgery 7

Combination Therapy

• The American College of Physicians recommends adding an intranasal antihistamine (azelastine) to intranasal corticosteroid therapy if monotherapy provides inadequate symptom control after 2-4 weeks, as combination intranasal therapy (fluticasone + azelastine) provides >40% relative improvement compared to either agent alone 8

Equivalence and Practical Use of Fluticasone Propionate vs Fluticasone Furoate for Allergic Rhinitis

Evidence of Therapeutic Equivalence

• The overall clinical response to intranasal corticosteroids does not differ significantly between products, regardless of differences in topical potency, lipid solubility, or receptor binding; this applies to fluticasone propionate and fluticasone furoate alike. 9, 10, 11

Onset of Action of Intranasal Corticosteroids

• Intranasal corticosteroids generally begin to relieve nasal symptoms within 3–12 hours after the first dose. 11

Practical Treatment Recommendations

Choice of Agent

• Either fluticasone propionate or fluticasone furoate can be selected for patients with persistent nasal symptoms, as both provide equivalent symptom control. 9, 10, 11

Optimizing Nasal Delivery

• Before starting an intranasal corticosteroid, ensure a patent nasal airway; if severe congestion is present, a short course (≤ 3 days) of a topical decongestant may be used to improve drug delivery. 11

Dosing Schedule

• Prescribe the intranasal corticosteroid for regular daily use throughout the allergen‑exposure season rather than on an as‑needed basis, because continuous therapy yields superior control of allergic rhinitis. 11